Brenda Libby Coleman

Array ( [id] => 928571 [patent_doc_number] => 07314881 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => '2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds' [patent_app_type] => utility [patent_app_number] => 10/819377 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 49415 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314881.pdf [firstpage_image] =>[orig_patent_app_number] => 10819377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5029137 [patent_doc_number] => 20070270584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Process for the Preparation of Steroidal Carbothioic Acid Derivatives and Intermediates' [patent_app_type] => utility [patent_app_number] => 10/552118 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7962 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270584.pdf [firstpage_image] =>[orig_patent_app_number] => 10552118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754645 [patent_doc_number] => 20060223794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Novel olanzapine forms and related methods of treatment' [patent_app_type] => utility [patent_app_number] => 10/551014 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13580 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223794.pdf [firstpage_image] =>[orig_patent_app_number] => 10551014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672869 [patent_doc_number] => 20040180910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Heterocycle carboxamides as antiviral agents' [patent_app_type] => new [patent_app_number] => 10/812229 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10642 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180910.pdf [firstpage_image] =>[orig_patent_app_number] => 10812229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 923134 [patent_doc_number] => 07319106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Diazabicyclic central nervous system active agents' [patent_app_type] => utility [patent_app_number] => 10/810999 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67335 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319106.pdf [firstpage_image] =>[orig_patent_app_number] => 10810999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292390 [patent_doc_number] => 07544681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Conjugated psychotropic drugs and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/808541 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 39 [patent_no_of_words] => 23479 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544681.pdf [firstpage_image] =>[orig_patent_app_number] => 10808541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101828 [patent_doc_number] => 20070185090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Muscarinic acetylchoine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/598887 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12298 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185090.pdf [firstpage_image] =>[orig_patent_app_number] => 10598887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101826 [patent_doc_number] => 20070185088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'M3 muscarinic acetylchoine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/598888 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33884 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185088.pdf [firstpage_image] =>[orig_patent_app_number] => 10598888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5593258 [patent_doc_number] => 20060157174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Mono amine and diamine derivatives of cl-20' [patent_app_type] => utility [patent_app_number] => 10/547260 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9442 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20060157174.pdf [firstpage_image] =>[orig_patent_app_number] => 10547260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 892300 [patent_doc_number] => 07345062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Substituted acylhydroxamic acids and method of reducing TNFαlevels' [patent_app_type] => utility [patent_app_number] => 10/786822 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14829 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345062.pdf [firstpage_image] =>[orig_patent_app_number] => 10786822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427383 [patent_doc_number] => 20040229879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'CRF receptor antagonists and methods relating thereto' [patent_app_type] => new [patent_app_number] => 10/785386 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9151 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229879.pdf [firstpage_image] =>[orig_patent_app_number] => 10785386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 695882 [patent_doc_number] => 07071331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Synthesis of quetiapine and pharmaceutically acceptable salts thereof' [patent_app_type] => utility [patent_app_number] => 10/785244 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3949 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071331.pdf [firstpage_image] =>[orig_patent_app_number] => 10785244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7422497 [patent_doc_number] => 20040265236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Trimeric macrocyclic substituted benzene derivatives' [patent_app_type] => new [patent_app_number] => 10/780887 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29265 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265236.pdf [firstpage_image] =>[orig_patent_app_number] => 10780887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820616 [patent_doc_number] => 07407949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Benzamide derivatives as oxytocin agonists and vasopressin antagonists' [patent_app_type] => utility [patent_app_number] => 10/541460 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18064 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 481 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407949.pdf [firstpage_image] =>[orig_patent_app_number] => 10541460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 925707 [patent_doc_number] => 07317005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-08 [patent_title] => 'Tricyclic benzodiazepines as vasopressin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/775675 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23174 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/317/07317005.pdf [firstpage_image] =>[orig_patent_app_number] => 10775675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978555 [patent_doc_number] => 20050288273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Antibacterial agents' [patent_app_type] => utility [patent_app_number] => 10/774241 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68043 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288273.pdf [firstpage_image] =>[orig_patent_app_number] => 10774241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5673004 [patent_doc_number] => 20060178359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Tricyclic compound, process for producing the same, and use' [patent_app_type] => utility [patent_app_number] => 10/544470 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47696 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178359.pdf [firstpage_image] =>[orig_patent_app_number] => 10544470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7238158 [patent_doc_number] => 20050080078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Method of treating addiction or dependence using a ligand for a monoamine receptor or transporter' [patent_app_type] => utility [patent_app_number] => 10/771519 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 82633 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080078.pdf [firstpage_image] =>[orig_patent_app_number] => 10771519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151876 [patent_doc_number] => 07678788 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Diazabicyclic aryl derivatives' [patent_app_type] => utility [patent_app_number] => 10/547157 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12066 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678788.pdf [firstpage_image] =>[orig_patent_app_number] => 10547157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200399 [patent_doc_number] => 20050165004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Bronchorelaxing compounds' [patent_app_type] => utility [patent_app_number] => 10/761323 [patent_app_country] => US [patent_app_date] => 2004-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17597 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165004.pdf [firstpage_image] =>[orig_patent_app_number] => 10761323 [rel_patent_id] =>[rel_patent_doc_number] =>)